Gerhardt Attard
Impact in
- Cancer Research top 0.2%
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
- Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 186
- Prostate Cancer Diagnosis and Treatment 30
- Oncology 71
- PARP inhibition in cancer therapy 23
- Cancer Treatment and Pharmacology 19
- Co-authors
- Johann S. de Bono (113 shared papers)Alison Reid (15 shared papers)Roberta Ferraldeschi (24 shared papers)Chris Parker (21 shared papers)David Olmos (36 shared papers)Carmel Pezaro (24 shared papers)David P. Dearnaley (24 shared papers)Stan B. Kaye (11 shared papers)
- Journals
- Journal of Clinical Oncology (79 papers)Annals of Oncology (36 papers)British Journal of Cancer (15 papers)Clinical Cancer Research (10 papers)European Urology (7 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Gerhardt Attard
241 papers receiving 11.3k citations
Gerhardt Attard's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 3.5k
- Pulmonary and Respiratory Medicine 7.1k
- Oncology 2.7k
- Endocrinology, Diabetes and Metabolism 1.3k
- Radiology, Nuclear Medicine and Imaging 1.2k
Countries citing papers authored by Gerhardt Attard
This map shows the geographic impact of Gerhardt Attard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhardt Attard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhardt Attard more than expected).
Fields of papers citing papers by Gerhardt Attard
This network shows the impact of papers produced by Gerhardt Attard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhardt Attard. The network helps show where Gerhardt Attard may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerhardt Attard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 252 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prostate cancer Hit paper breakdown → | 2015 | 718 |
| 2 | Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven Hit paper breakdown → | 2008 | 667 |
| 3 | Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer Hit paper breakdown → | 2009 | 449 |
| 4 | ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group Hit paper breakdown → | 2022 | 403 |
| 5 | 2007 | 344 | |
| 6 | Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2015 | 295 |
| 7 | 2010 | 292 | |
| 8 | 2013 | 276 | |
| 9 | 2014 | 254 | |
| 10 | 2011 | 217 | |
| 11 | 2010 | 201 | |
| 12 | 2012 | 201 | |
| 13 | 2007 | 199 | |
| 14 | 2008 | 195 | |
| 15 | 2012 | 194 | |
| 16 | 2009 | 190 | |
| 17 | 2010 | 171 | |
| 18 | 2018 | 163 | |
| 19 | 2013 | 160 | |
| 20 | 2014 | 157 |
About Gerhardt Attard
Gerhardt Attard is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 252 papers that have together received 11.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (186 papers), Radiopharmaceutical Chemistry and Applications (56 papers), Cancer Genomics and Diagnostics (34 papers), Prostate Cancer Diagnosis and Treatment (30 papers), Cancer, Lipids, and Metabolism (27 papers), PARP inhibition in cancer therapy (23 papers), Cancer Treatment and Pharmacology (19 papers) and Hormonal and reproductive studies (16 papers). The work is most often cited by research in Cancer Research (3.5k citations), Pulmonary and Respiratory Medicine (7.1k citations), Oncology (2.7k citations), Endocrinology, Diabetes and Metabolism (1.3k citations) and Radiology, Nuclear Medicine and Imaging (1.2k citations). Gerhardt Attard has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Johann S. de Bono, Alison Reid, Roberta Ferraldeschi, Chris Parker, David Olmos, Carmel Pezaro, David P. Dearnaley, Stan B. Kaye, Colin S. Cooper and Ian F. Tannock. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Clinical Cancer Research and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.